Evidenced-based Approach to Management of High-risk Head and Neck Cutaneous Squamous Cell Carcinoma, 2026 Update

Sunday, October 18, 2026

4:00 PM - 5:00 PM PT

Location: West Exhibit Hall A, Learning Zone 3

Lead Presenter(s)

Karen Y. Choi, MD

Associate Professor
MD Anderson Cancer Center
Houston, Texas, United States

Mentor(s)

NG

Neil D. Gross, MD

Professor
MD Anderson Cancer Center
Houston, Texas, United States

Co-Presenter(s)

TO

Thomas J. Ow, MD

Associate Attending
Memorial Sloan Kettering Cancer Center
New York City, New York, United States

Attendees at this panel will learn about evolving and contemporary evidence in cutting-edge strategies for the management of high-risk CSCC of the head and neck, including work-up and identification of high-risk disease, use of sentinel lymph node biopsy and gene expression profiling, and perioperative immunotherapy.

Learning Objectives:

To understand recent advances in the treatment of high-risk cutaneous squamous cell carcinoma (CSCC) of the head and neck.
To describe the current evidence supporting treatment strategies for high-risk CSCC of the head and neck.
To understand the potential application of perioperative immunotherapy strategies for advanced CSCC.